What if cancer cells could be re-engineered to turn against their own kind?
A new study in Science Translational Medicine, led by researchers at Brigham and Women’s Hospital, leverages the power of gene editing to take a critical step toward using cancer cells to kill cancer. The team reports promising results in preclinical models across multiple types of cancer cells, establishing a potential roadmap toward clinical translation for treating primary, recurrent and metastatic cancer.
“This is just the tip of the iceberg,” said corresponding author Khalid Shah MS, PhD, director of the Center for Stem Cell Therapeutics and Imaging (CSTI) in the BWH Department of Neurosurgery and faculty at Harvard Medical School and Harvard Stem Cell Institute (HSCI). “Cell-based therapies hold tremendous promise for delivering therapeutic agents to tumors and may provide treatment options where standard therapy has failed. With our technique, we show it is possible to reverse-engineer a patient’s own cancer cells and use them to treat cancer. We think this has many implications and could be applicable across all cancer cell types.”
The new approach capitalizes on cancer cells’ self-homing ability – the process in which cancer cells can track the cells of their kind that have spread within the same organ or to other parts of the body. Harnessing this power could overcome drug delivery challenges, helping get therapeutics to tumor sites that may otherwise be difficult to reach.
The team developed and tested two techniques to harness the power of cancer cells. The “off the shelf” technique used pre-engineered tumor cells that would need to be matched to a patient’s HLA phenotype (essentially, a person’s immune fingerprint). The “autologous” approach used CRISPR technology to edit the genome of a patient’s cancer cells and insert therapeutic molecules. These cells could then be transferred back into the patient.
To test both approaches, the team used mouse models of primary and recurrent brain cancer and breast cancer that has spread to the brain. The team saw direct migration of engineered cells to the sites of tumors and found evidence that the engineered cells specifically targeted and killed recurrent and metastatic cancer in the mice. The researchers report that the treatment increased the survival of the mice. Engineered cells were equipped with a “kill switch” that could be activated after treatment – PET imaging showed that this kill switch worked to eliminate the cells.
“Our study demonstrates the therapeutic potential of using engineered tumor cells and their self-homing properties for developing receptor-targeted therapeutics for various cancers,” said Shah.
The Latest on: Engineered cancer cells
via Google News
The Latest on: Engineered cancer cells
- NHS England to fund engineered cell therapy for adults with aggressive lymphoma on October 5, 2018 at 3:23 am
When the engineered cells are given back to the patient, they are primed to recognise and attack the cancer cells. The treatment will be offered to patients with two aggressive types of non-Hodgkin ly... […]
- Engineered natural killer cells may be the next great cancer immunotherapy on September 14, 2018 at 10:09 am
The cancer fighters known as CAR T cells have proved their prowess in recent years. Three therapies using the altered T cells against lymphoma or leukemia have won U.S. Food and Drug Administration ap... […]
- Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer on August 19, 2018 at 6:09 pm
SINGAPORE, Aug. 19, 2018 /PRNewswire/ -- Lion TCR Pte. Ltd., a Singapore-based Biotech company receives approval from Health Sciences Authority (HSA), Singapore, for its Phase I/II multicentre clinica... […]
- Singapore's first clinical trial approval for T cell engineered (TCR) immunotherapy for treatment of Liver cancer on August 18, 2018 at 5:00 pm
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliate... […]
- Kashmiri scientist leads a research to fight cancer with ‘engineered’ cancer cells on July 24, 2018 at 4:07 pm
A US-based Kashmiri scientist is heading a study by team of researchers to treat cancer using “engineered” cancer cells. Under the technique titled “Kill Switch” the scientists are focusing on gene ed... […]
- Researchers create cancer cells that kill their own kind on July 13, 2018 at 1:31 am
Cancer cells circulating in the bloodstream have something of a homing instinct, able to find and return to the tumor where they originated. To capitalize on that ability, researchers engineered these ... […]
- Boston researchers re-engineer cancer cells to fight off 'their own kind' on July 12, 2018 at 10:36 am
... techniques to use the power of the cancer cells. To test both approaches, the team used mouse models of primary and recurrent brain cancer and breast cancer that has spread to the brain. The re-en... […]
- Engineered Cancer Cells Can Fight Cancer, Brigham And Women's Researchers Find on July 11, 2018 at 3:23 pm
A study led by researchers at Brigham and Women's Hospital finds that CRISPR-enhanced, reverse-engineered cancer cells can be used to kill that cancer from within. The researchers tested two different ... […]
- Engineered cancer cells can fight primary and metastatic cancer on July 11, 2018 at 11:03 am
In this image, CRISPR-engineered therapeutic cancer cells (green) track primary cancer cells (red) in the brain. Credit: CSTI/Khalid Shah lab What if cancer cells could be re-engineered to turn agains... […]
via Bing News